Related references
Note: Only part of the references are listed.Worldwide prevalence of smoking cessation in schizophrenia patients: A meta-analysis of comparative and observational studies
Liang-Nan Zeng et al.
ASIAN JOURNAL OF PSYCHIATRY (2020)
Approved and emerging smoking cessation treatments for people with schizophrenia spectrum disorders: A narrative review
Pasquale Caponnetto et al.
HEALTH PSYCHOLOGY RESEARCH (2020)
Pharmacological and behavioural interventions to promote smoking cessation in adults with schizophrenia and bipolar disorders: a systematic review and meta-analysis of randomised trials
Robert Pearsall et al.
BMJ OPEN (2019)
Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity
Faith Dickerson et al.
PSYCHIATRIC SERVICES (2018)
Current Cigarette Smoking Among Adults - United States, 2016
Ahmed Jamal et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
Saeed Ahmed et al.
FRONTIERS IN PSYCHIATRY (2018)
CAUSES OF MORTALITY IN SCHIZOPHRENIA: AN UPDATED REVIEW OF EUROPEAN STUDIES
Patryk Piotrowski et al.
PSYCHIATRIA DANUBINA (2017)
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Robert M. Anthenelli et al.
LANCET (2016)
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
Robert C. Smith et al.
PLOS ONE (2016)
How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview
B. Stubbs et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis
Alex J. Mitchell et al.
GENERAL HOSPITAL PSYCHIATRY (2015)
Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) Study: The moderating role of smoking status and antipsychotic medications
Junghee Lee et al.
SCHIZOPHRENIA RESEARCH (2015)
Smoking Behaviour and Mental Health Disorders-Mutual Influences and Implications for Therapy
Amedeo Minichino et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2013)
Interventions for smoking cessation and reduction in individuals with schizophrenia
Daniel T. Tsoi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis
Elaine Weiner et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications
Michael Beary et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
Jennifer W. Tidey et al.
PSYCHOPHARMACOLOGY (2011)
Cigarette Smoking and Mortality Risk in People With Schizophrenia
Deanna L. Kelly et al.
SCHIZOPHRENIA BULLETIN (2011)
Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program
Monica C. Mann-Wrobel et al.
SCHIZOPHRENIA RESEARCH (2011)
Interventions for smoking cessation and reduction in individuals with schizophrenia
Daniel T. Tsoi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder
Jill M. Williams et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Global mental health 1 - No health without mental health
Martin Prince et al.
LANCET (2007)
A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia
A. Eden Evins et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
A perfect platform: Combining contingency management with medications for drug abuse
Kathleen M. Carroll et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2007)
Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?
Mark Barnes et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2006)
Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited
Rael D. Strous et al.
JOURNAL OF AUTOIMMUNITY (2006)
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
J de Leon et al.
SCHIZOPHRENIA RESEARCH (2005)
Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?
DE McChargue et al.
ADDICTION (2002)
Substance misuse in patients with schizophrenia - Epidemiology and management
DJ Kavanagh et al.
DRUGS (2002)
Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia
E Weiner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia
TP George et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
